These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 25511766)
1. Editorial: prolonged remission from hepatic encephalopathy with rifaximin. Orr JG; Hudson M Aliment Pharmacol Ther; 2015 Jan; 41(2):228. PubMed ID: 25511766 [No Abstract] [Full Text] [Related]
2. Prolonged remission from hepatic encephalopathy with rifaximin: results of a placebo crossover analysis. Bajaj JS; Barrett AC; Bortey E; Paterson C; Forbes WP Aliment Pharmacol Ther; 2015 Jan; 41(1):39-45. PubMed ID: 25339518 [TBL] [Abstract][Full Text] [Related]
3. Durability of rifaximin response in hepatic encephalopathy. Neff GW; Jones M; Broda T; Jonas M; Ravi R; Novick D; Kaiser TE; Kemmer N J Clin Gastroenterol; 2012 Feb; 46(2):168-71. PubMed ID: 22011586 [TBL] [Abstract][Full Text] [Related]
4. [Rifaximin in the treatment of hepatic encephalopathy]. Lata J; Hůlek P; Fejfar T; Spicák J; Drastich P; Marecek Z; Brůha R; Husová L; Senkyrík M Vnitr Lek; 2002 Jun; 48(6):578-82. PubMed ID: 12132365 [TBL] [Abstract][Full Text] [Related]
5. [Rifaximin for hepatic encephalopathy in children. Case report]. Malla I; Torres Cerino V; Villa A; Cheang Y; Giacove G; Pedreira A; Silva M Arch Argent Pediatr; 2011 Dec; 109(6):e113-5. PubMed ID: 22231877 [TBL] [Abstract][Full Text] [Related]
8. Rifaximin: an alternative for the treatment of hepatic encephalopathy. Rigali VT Conn Med; 2006 Sep; 70(8):499-501. PubMed ID: 17089807 [No Abstract] [Full Text] [Related]
9. Rifaximin treatment in hepatic encephalopathy. Wang CC; Kao JH N Engl J Med; 2010 Jun; 362(25):2423; author reply 2424-5. PubMed ID: 20573932 [No Abstract] [Full Text] [Related]
10. RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial. Schulz C; Schütte K; Kropf S; Schmitt FC; Vasapolli R; Kliegis LM; Riegger A; Malfertheiner P Trials; 2016 Feb; 17(1):111. PubMed ID: 26926775 [TBL] [Abstract][Full Text] [Related]
11. Rifaximin treatment in hepatic encephalopathy. Xue T; Qiu JH; Qiao L N Engl J Med; 2010 Jun; 362(25):2424; author reply 2424-5. PubMed ID: 20578275 [No Abstract] [Full Text] [Related]
12. Rifaximin treatment in hepatic encephalopathy. Sharma P; Sharma BC N Engl J Med; 2010 Jun; 362(25):2423-4; author reply 2424-5. PubMed ID: 20578274 [No Abstract] [Full Text] [Related]
13. Gut flora and hepatic encephalopathy in patients with cirrhosis. Riordan SM; Williams R N Engl J Med; 2010 Mar; 362(12):1140-2. PubMed ID: 20335591 [No Abstract] [Full Text] [Related]
14. Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy. Kang SH; Lee YB; Lee JH; Nam JY; Chang Y; Cho H; Yoo JJ; Cho YY; Cho EJ; Yu SJ; Kim MY; Kim YJ; Baik SK; Yoon JH Aliment Pharmacol Ther; 2017 Nov; 46(9):845-855. PubMed ID: 28836723 [TBL] [Abstract][Full Text] [Related]
15. Rifaximin is an efficacious treatment for the Parkinsonian phenotype of hepatic encephalopathy. Kok B; Foxton MR; Clough C; Shawcross DL Hepatology; 2013 Oct; 58(4):1516-7. PubMed ID: 23471844 [No Abstract] [Full Text] [Related]